Nachrichten zur Ampio Pharmaceuticals Inc. Aktie

Redhill Biopharma, Ampio Pharmaceuticals among healthcare movers

…

Form 8-K Ampio Pharmaceuticals, For: Nov 17

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ampio Pharmaceuticals announces NYSE American removal of trading suspension

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension

ENGLEWOOD, Colo., Nov. 17, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE) (the "Company") received notification from NYSE…

Form 10-Q Ampio Pharmaceuticals, For: Sep 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Ampio Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2022 - (NYSE: AMPE)

NEW YORK, Oct. 19, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ampio Pharmaceuticals,…

Form 8-K Ampio Pharmaceuticals, For: Oct 13

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ampio Pharmaceuticals Issues Letter to Stockholders

Proposal to Authorize Reverse Stock Split has Been Approved ENGLEWOOD, Colo., Oct. 14, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE…

AMPE SHAREHOLDER ALERT: Jakubowitz Law Reminds Ampio Shareholders of a Lead Plaintiff Deadline of October 17, 2022

NEW YORK, Oct. 14, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…

AMPE Investors Have Opportunity to Lead Ampio Pharmaceuticals, Inc. Securities Fraud Lawsuit

LOS ANGELES, Oct. 13, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have…

AMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Oct. 13, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Ampio Pharmaceuticals, Inc. ("Ampio" or the…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Ampio Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2022 - (NYSE: AMPE)

NEW YORK, Oct. 12, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ampio Pharmaceuticals,…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ampio Pharmaceuticals, Inc. - AMPE

NEW YORK, Oct. 10, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ampio Pharmaceuticals, Inc.…

ROSEN, LEADING INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

NEW YORK, Oct. 7, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…

AMPE SHAREHOLDER ALERT: Jakubowitz Law Reminds Ampio Shareholders of a Lead Plaintiff Deadline of October 17, 2022

NEW YORK, Oct. 7, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…

AMPE Investors Have Opportunity to Lead Ampio Pharmaceuticals, Inc. Securities Fraud Lawsuit

LOS ANGELES, Oct. 6, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses…

AMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Oct. 6, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Ampio Pharmaceuticals, Inc. ("Ampio" or the…

XFRA : Deletion of Instruments from Boerse Frankfurt - 04.10.2022

The following instruments on Boerse Frankfurt do have their last trading day on 04.10.2022. Die folgenden Instrumente in Boerse Frankfurt haben…

Ampio Pharmaceuticals Announces NYSE American Has Commenced Delisting Proceedings

ENGLEWOOD, Colo., Oct. 4, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") received written notification from NYSE…

Form 8-K Ampio Pharmaceuticals, For: Oct 03

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

AMPE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 17, 2022 in the Class Action Filed on Behalf of Ampio Pharmaceuticals, Inc. Shareholders

NEW YORK, Oct. 4, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…

XFRA : APH: Aussetzung/Suspension

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

XFRA : INSTRUMENT_SUSPENSION - US03209T1097

Instrument ID [7093] (APH - US03209T1097) suspended...…

dpa-AFX ProFeed